Back to search

Article

The Aryl Hydrocarbon Receptor Controls IFNγ-Induced Immune Checkpoints PD-L1 and IDO via the JAK/STAT Pathway in Lung Adenocarcinoma

2024-08-13

Abstract excerpt

While immunotherapy has shown efficacy in lung adenocarcinoma (LUAD) patients, many respond only partially or not at all. One limitation in improving outcomes is the lack of a complete understanding of immune checkpoint regulation. Here, we investigated a possible link between an environmental chemical receptor implicated in lung cancer and immune regulation, ( the aryl hydrocarbon receptor/AhR), a known but coun...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7b5f51ab-7301-5d84-b987-0422eb98c011
DOI
10.1101/2024.08.12.607602
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Aryl Hydrocarbon Receptor Controls IFNγ-Induced Immune Checkpoints PD-L1 and IDO via the JAK/STAT Pathway in Lung AdenocarcinomaDOI 10.1101/2024.08.12.607602
Select a neighboring publication to make it the new centre.